A4 Dementia - stemming the tide
Wednesday 31 August 2016
14:30-17:30
Hilton Buenos Aires : Pacara A & B, 3 hours
Organised by the FIP Special Interest Group on Translational Research and Individualized Medicines and the FIP Hospital Pharmacy Section
Introduction
Dementia is one of the biggest global public health challenges. Recent advances in medical technology, including imaging, have enabled a more detailed understanding of the impact of early
diagnosis in personalised medicine. Pharmacists need to know the importance of an earlyintervention - before organic lesions start to appear - to prevent dementia.
Social problems can be prevented through the education of and interactive communication between all stakeholders such as researchers, practitioners and patients. Pharmacists should participate actively to stem the tide dementia.
Learning objectives
At the conclusion of this knowledge-based session, participants will be able to:
- Identify the role of pharmacists in responding to the challenges of dementia
- Explain the disruptive technology for individual disease profiling
- Outline the perspectives on dementia and the impact of early intervention on society
- Specify the importance of patient-centred pharmaceutical care for dementia therapy
Chair
Hitoshi Sasaki (Nagasaki University, Japan)
Programme
14:30
1) Current topics of dementia
Kiyofumi Yamada (Nagoya University Hospital, Japan)
15:10
2) Disruptive technology for individual disease profiling
Eduardo Savio (Radiopharmacy R&D Directive Board Uruguayan Centre for Molecular Imaging, Uruguay)
15:50 – 16:10 Coffee/tea break
16:10
3) Impact of early intervention in society
Claire Anderson (University of Nottingham, UK)
16:50
4) Patient-centred pharmaceutical care
Sean Jeffery (University of Connecticut, USA)
